Total Funding
91
87
Total FundingPost-IPO Debt raised
Growth Score
-4 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3613
Organon develops and provides medicines and health solutions focused on women’s health, biosimilars, and established brands.
Acquired by 
Sun Pharmaceutical
- Andreas Jørgensen: Managing Director, Asia Pacific
Christina Marzocca: Executive Clinical Account Specialist
About the Company
Organon develops and provides medicines and health solutions focused on women’s health, biosimilars, and established brands. The company offers treatments for contraception, fertility, menopause, and conditions such as endometriosis, along with therapies addressing cardiovascular and respiratory diseases through its established portfolio. It also
develops and commercializes biosimilar products that aim to expand access to biologic treatments. Organon collaborates with healthcare providers, governments, and partners to support education, access, and delivery of care. Its operations include research, manufacturing, and distribution of pharmaceutical products across multiple therapeutic areas.
